Search Site
Related Products
CNX1351PI3Kα inhibitor

CNX1351

Catalog No. B5821
Size Price Stock
5mg Please Inquire Please Inquire
10mg Please Inquire Please Inquire
50mg Please Inquire Please Inquire

Tel: +1-832-696-8203

Email: sales@apexbt.com

Worldwide Distributors

Sample solution is provided at 25 µL, 10mM.

Quality Control

Quality Control & MSDS

View current batch:

Chemical structure

CNX1351

CNX1351 Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

CNX1351 Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Chemical Properties

Cas No. 1276105-89-5 SDF Download SDF
Chemical Name 1-(4-((2-(1H-indazol-4-yl)-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl)piperazin-1-yl)-6-methylhept-5-ene-1,4-dione
Canonical SMILES C/C(C)=C\C(CCC(N1CCN(CC(S2)=CC3=C2C(N4CCOCC4)=NC(C5=C6C=NNC6=CC=C5)=N3)CC1)=O)=O
Formula C30H35N7O3S M.Wt 573.71
Solubility Soluble in DMSO Storage Store at -20°C
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
Shipping Condition Evaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request

Background

CNX1351 is a potent and selective inhibitor of PI3Kα with IC50 value of 6.8 nM [1] [2].

Phosphoinositide 3-kinases (PI3Ks) are a family of lipid kinases that phosphorylating the 3’-hydroxyl group of phosphatidylinositol-4,5-bisphosphate (PIP2) to produce phosphatidylinositol-3,4,5-trisphosphate (PIP3). PI3Ks plays important roles in cell proliferation, survival, differentiation and metabolism [1] [2].

CNX1351 is a specific and covalent PI3Kα inhibitor. CNX1351 time-dependently and irreversibly inhibited PI3Kα, PI3Kβ, PI3Kγ and PI3Kδ with IC50 values of 6.8, 166.0, 240.3 and 3020.0 nM, respectively. In SKOV3 ovarian cancer cells with a mutation in PIK3CA that resulted in a constitutively activated PI3Kα, CNX1351 inhibited PI3K signaling with EC50 values of 10-100 nM. In MCF-7 breast cancer cells (E545K) and SKOV3 ovarian cancer cells (H1047R) with different PIK3CA activating mutations, CNX1351 inhibited cell growth with GI50 values of 55 and 78 nM, respectively [1].

In nude mice, CNX1351 (100 mg/kg ip) irreversibly bonded to p110α and inhibited P-AktSer473 expression [1].

References:
[1].  Nacht M, Qiao L, Sheets MP, et al. Discovery of a potent and isoform-selective targeted covalent inhibitor of the lipid kinase PI3Kα. J Med Chem, 2013, 56(3): 712-721.
[2].  Jeong Y, Kwon D, Hong S. Selective and potent small-molecule inhibitors of PI3Ks. Future Med Chem, 2014, 6(7): 737-756.